ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

Vitamin D, Calcium Supplements May Not Lower Fracture Risk

Lisa Rapaport  |  

(Reuters Health)—Older adults who take vitamin D and calcium are no less likely to break their hips or other bones than peers who don’t use these supplements, a research review suggests. Researchers examined data from 33 previous trials with a total of more than 51,000 people aged 50 or older who were living in the…

Predatory Publishing: Know the Difference Between a Financial Scheme and Scholarly Dissemination

  |  

It happens every day. A new email pops up in a researcher’s in-box from a journal with a seemingly familiar name and an invitation to publish a research paper, present at a meeting or, perhaps, serve on an editorial board. Like many of her colleagues, Marian Hannan, DSc, MPH, professor of medicine at Harvard Medical…

Rheumatology Research Foundation Hosts Student, Resident Experience at ACR/ARHP Annual Meeting

  |  

On Nov. 5, more than 100 students and residents gathered for the Rheumatology Research Foundation’s Student and Resident Experience at the ACR/ARHP Annual Meeting in San Diego. As part of the Foundation’s work to increase the number of rheumatology professionals in the U.S., the event is designed to increase excitement in the field. Attendees enjoyed…

Rheumatologist Deborah Desir Brings Advocacy, Fundraising to the Home Front

  |  

When former ACR President Joseph Flood, MD, tapped Deborah Dyett Desir, MD, to volunteer for an ACR committee, he might have assumed that her preference would be to serve on the Committee on Rheumatologic Care or its Insurance Subcommittee. After all, Dr. Desir is in private practice at the Arthritis and Osteoporosis Center PC in…

The ACR Maintains Seat at the AMA Table, Achieves Successful Resolutions at HOD Meeting

  |  

Together our voice is heard; our influence is alive. In 2017, ACR members heard the call of the Rheumatology Strong campaign and joined the American Medical Association (AMA) in force, ensuring the College maintains its representation in the country’s largest—and arguably most influential—physician society. “We surpassed our minimum 1,000-member goal by a margin and are hopeful…

Meet Incoming Rheumatology Research Foundation President Abby Abelson, MD, FACR

  |  

When Abby Abelson, MD, FACR, chair of the Department of Rheumatology and Immunologic Disease at Cleveland Clinic, was in medical school, she enjoyed nearly every one of her rotations. But it was the rheumatology patients who inspired her the most. “I saw they had challenges in their lives that they were able to triumph over,”…

ARHP Master Designation Award Will Debut at the 2018 ACR/ARHP Annual Meeting

Elizabeth A. Schlenk, PhD, RN, FAAN, & Afton L. Hassett, PsyD  |  

The ACR Board of Directors approved the ARHP Master Designation at its August 2017 meeting. The first two ARHP Master Designation awardees will be honored at the ACR/ARHP Annual Meeting in Chicago on Oct. 20, 2018. Recognition as a Master of the ARHP is one of the highest honors that the ARHP bestows to members….

Rheumatologist Channels Military Aspirations into Role with U.S. Navy Reserve

  |  

In 2010, Thomas Bartow, MD, FACP, finally ran out of excuses. Ever since high school, he had wanted to join the military. But too many things got in the way—like attending medical school at State University of New York at Stony Brook. After graduation in 1980, he performed his residency in internal medicine at Rush-Presbyterian-St….

Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA

Nan Yang, PharmD, & Kurt Oelke, MD, on behalf of the ARHP Practice Committee  |  

Two decades have passed since the first biologic disease-modifying anti-rheumatic drug (bDMARD) was approved. Studies on the long-term use of biologics in different disease states, such as for cardiovascular disease (CVD) and malignancy, as well as for knee/hip replacement, reveal some encouraging news. In clinical trials, bDMARDs have been shown to increase the risk of…